EUVIMEDEUVIMED entdecken
Crossref

Identification of Amino Acid Residues, Distal to the Peptide‐Binding Domain, That Confer Serological Distinctions Within Each HLA‐DQB1*02 , *03 , *05 and *06 Antigen Group

Tina Meng iD, Ujjwala Singh iD, Naiiry Petrosyan iD, Fred Quiroz iD, Xiaoliang Yao iD, Than Than Han iD, Hsiao-Min Chang iD, Eric Ka-Wai Hui iD, David Suh iD, Vincent Ma iD, Elaina Rybak iD, Quansheng Zhu iD und 6 weitere

HLA · 2026

DOI: 10.1111/tan.70835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HLA, 2026. Verfasst von Tina Meng und 17 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Transplant Diagnostics, Thermo Fisher Scientific Inc., West Hills, California, USA. Hauptthemen laut MEDLINE: HLA-DQ beta-Chains, Epitopes, B-Lymphocyte, Peptides, Amino Acids. Die Arbeit nennt 18 Literaturangaben. Gefördert von: Thermo fisher Scientific.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identifying HLA amino acid residues that account for an observed specificity (reactivity profile) is critical for serological categorisation at B‐cell epitope level. Human monoclonal antibody, LB_DQB0501_C (hIgG1l), produced by an individual typed DQA1*01:02 , DQA1*03:01 , DQB1*03:02 , DQB1*06:09 against an immuniser typed DQA1*01:01 , DQA1*01:02 , DQB1*05:01 , DQB1*06:09 , reacts strongly to many but not all DQB1*02 , *03 , *05 and *06 single antigen beads. Within each first‐field molecular typing group, some beads were recognised weakly by the antibody or not at all even at 10 μg/mL. Only one prediction (DQB1_130R185T as a pair) was made using AminoAcid3D (AA3D), an algorithm that defines each HLA molecule as a series of overlapping 3‐dimensional clusters and deduces the potential essential region that could account for an observed reactivity profile. Among various scenarios, DQB1_130R185T was predicted only when the weak signals (TMFI about 1000) were included as positive. Both 130R and 185T, about 10 Å apart, were confirmed as essential for binding using engineered variants as the change of either led to complete loss of binding in both cell and bead assays. Additional residues in the vicinity were also tested for their relative contributions. Besides polymorphic residues in DQB1 at positions 135 or likely 182 that could explain the signal differences within each DQB1*02 or DQB1*05 group, three conserved residues (DQB1_132F, _174H and _183P) were also shown to be critical in securing the binding, indicating multiple residues including conserved are needed to maintain a stable interaction. Epitopes distal to the peptide‐binding domains have not been sufficiently described by the conventional serological typing. Even using HLAMatchmaker, 130R185T was not predicted despite both 130R (verified, level A2) and 185T (unverified) are listed separately as an HLA‐DQ eplet in HLA Eplet Registry. This study provides evidence that AA3D is a useful research tool for epitope analysis. Once a predicted specificity determinant is experimentally verified, both polymorphic and conserved positions nearby should be further investigated for their contributions to the epitope. Such knowledge could become the basis of the ongoing efforts in serological categorisation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HLA-DQ beta-ChainsEpitopes, B-LymphocytePeptidesAmino AcidsHumansAntibodies, MonoclonalHistocompatibility TestingProtein BindingEpitope MappingAmino Acid SequenceAlleles

Stichwörter der Autor:innen

AminoAcid3D (AA3D)HLAdonor specific antibody (DSA)engineered variantepitope analysisessential regionhuman monoclonal antibodyreactivity profilesingle antigen bead (SAB)

Substanzen

HLA-DQ beta-ChainsHLA-DQB1 antigenAntibodies, MonoclonalEpitopes, B-LymphocytePeptidesAmino Acids

Autor:innen und Institutionen

  • Research and Development, Transplant Diagnostics, Thermo Fisher Scientific Inc., West Hills, California, USA.
  • Software Engineering, Transplant Diagnostics, Thermo Fisher Scientific Inc., West Hills, California, USA.
  • Customer Experience, Transplant Diagnostics, Thermo Fisher Scientific Inc., West Hills, California, USA.
  • Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.

ORCID-Profile: Tina Meng, Ujjwala Singh, Naiiry Petrosyan, Fred Quiroz, Xiaoliang Yao, Than Than Han, Hsiao-Min Chang, Eric Ka-Wai Hui, David Suh, Vincent Ma, Elaina Rybak, Quansheng Zhu, Zhifang Wang, James Jones, Dave Roelen, Cynthia S M Kramer, Sebastiaan Heidt, Dave Lowe

Förderung

  • Thermo fisher Scientific

Zitieren

APA

Meng, T., Singh, U., Petrosyan, N., Quiroz, F., Yao, X., Han, T. T., Chang, H. M., Hui, E. K., Suh, D., Ma, V., Rybak, E., Zhu, Q., Wang, Z., Jones, J., Roelen, D., Kramer, C. S. M., Heidt, S., & Lowe, D. (2026). Identification of Amino Acid Residues, Distal to the Peptide‐Binding Domain, That Confer Serological Distinctions Within Each HLA‐DQB1*02 , *03 , *05 and *06 Antigen Group. HLA. https://doi.org/10.1111/tan.70835

Vancouver

Meng T, Singh U, Petrosyan N, Quiroz F, Yao X, Han TT, et al. Identification of Amino Acid Residues, Distal to the Peptide‐Binding Domain, That Confer Serological Distinctions Within Each HLA‐DQB1*02 , *03 , *05 and *06 Antigen Group. HLA. 2026. doi:10.1111/tan.70835

BibTeX
@article{Meng2026,
  author = {Meng, Tina and Singh, Ujjwala and Petrosyan, Naiiry and Quiroz, Fred and Yao, Xiaoliang and Han, Than Than and Chang, Hsiao-Min and Hui, Eric Ka-Wai and Suh, David and Ma, Vincent and Rybak, Elaina and Zhu, Quansheng and Wang, Zhifang and Jones, James and Roelen, Dave and Kramer, Cynthia S M and Heidt, Sebastiaan and Lowe, Dave},
  title = {Identification of Amino Acid Residues, Distal to the Peptide‐Binding Domain, That Confer Serological Distinctions Within Each HLA‐DQB1*02 , *03 , *05 and *06 Antigen Group},
  journal = {HLA},
  year = {2026},
  doi = {10.1111/tan.70835}
}
Kostenlos starten →